Locations:

Cancer

December 4, 2023/Cancer/Blood Cancers

Ten ASH Presentations You Don’t Want to Miss

Cleveland Clinic oncologists’ selected abstracts

December 4, 2023/Cancer

First of Its Kind: Oncology Pharmacovigilance Clinic

Multidisciplinary care for patients with immune-related adverse events

23-CNR-4259358-CQD-Hero-Dr Hamilton 650×450

November 28, 2023/Cancer/Research

Study Demonstrates Fewer Toxicities and Faster Engraftment with Reduced-Dose Methotrexate for Preventing Graft-Versus-Host Disease

Researchers compared tacrolimus/methotrexate to tacrolimus and reduced-dose methotrexate/mycophenolate

22-CNR-3127708-CQD-Hero2-650×450-credits

November 22, 2023/Cancer/Radiation Oncology

A Germline Biomarker Offers Insight Into Treatment Selection for Men With Prostate Cancer

Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-CNR-4283974-CQD-Hero-650×450 palliative care

November 15, 2023/Cancer/Patient Support

Symptom Resolution Achieved in More than 90 Percent of Patients Under Palliative Care

Newer medications pivotal for improving gastrointestinal symptoms in patients with cancer

November 7, 2023/Cancer/Research

Low-Dose Radiation Therapy Reemerging for Osteoarthritis

Cleveland Clinic radiation oncologists aim to bring the noninvasive approach back to the U.S., where use has declined

November 2, 2023/Cancer/Radiation Oncology

Studying Ultra-Hypofractionated Radiotherapy for Soft Tissue Sarcoma

Meta-analysis suggests efficacy and safety

23-CNR-4274323-CQD-pagets disease of the breast

October 30, 2023/Cancer/Surgical Oncology

Paget’s Disease of the Breast a Little Understood Form of DCIS

Rare cancer presents as unresolved changes of the nipple

23-CNR-4270908-CQD-Hero-Dr Mukherjee rare cancers 650×450

October 26, 2023/Cancer/News & Insight

Cleveland Clinic Cancer Center and National Organization for Rare Disorders Partner to Accelerate Diagnosis and Treatment of Rare Cancers

Dedicated multidisciplinary teams support 84 ultra-rare cancers

October 23, 2023/Cancer/Research

p53-Independent Non-Cytotoxic Therapy May be a Viable Option for Chemotherapy-Resistant Small Cell Lung Cancer

Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC

BackPage 4 of 140Next